EGFR and cancer: ExoDx Lung (ALK) accurately identifies the EML4-ALK mutation in cancer cells by analyzing exosomal RNAs in the blood, while ExoDx Lung (T790M) detects the EGFR T790M mutation, and ExoDx Lung (EGFR) identifies both EGFR activation and T790M resistance mutations.